All
Andrology
Astronomy
Biochemistry
Bioinformatics
Biology
Biophysics
Biotechnology
Botany
Cardiology
Cell Biology
Chemistry
Dermatology
Ecology
Epidemiology
Evolutionary Biology
General
Genetics
Genomics
Geology
Geriatrics
Gynaecology
Immunology
Informatics
Mathematics
Medicine
Microbiology
Molecular Biology
Neurology
Nutrition
Oncology
Pathology
Pediatrics
Pharmacology
Philosophy
Physics
Physiology
Psychiatry
Psychology
Statistics
Surgery
Toxicology
Urology
Virology
Zoology
Programmed death-ligand 1 monoclonal antibody-linked immunoliposomes for synergistic efficacy of miR-130a and oxaliplatin in gastric cancers
(Nanomedicine)
19 july 2019 07:00:11
Programmed death-ligand 1 monoclonal antibody-linked immunoliposomes for synergistic efficacy of miR-130a and oxaliplatin in gastric cancers
(Nanomedicine)
Tweet
Nanomedicine, Volume 14, Issue 13, Page 1729-1744, July 2019.
164 views
Category:
Medicine
,
Physics
Assembly simulation and synergistic chemotherapy of TPGS derivative functionalized polymersomes in hepatocellular carcinoma
(Nanomedicine)
Analysis of inequality in nanomedicine using clinical trials and disease burden
(Nanomedicine)
Please enable JavaScript to view the
comments powered by Disqus.
blog comments powered by
Disqus
MyJournals.org
The latest issues of all your favorite science journals on one page
Username:
Password:
Register
|
Retrieve
Search:
Google:
Copyright © 2008 - 2024
Indigonet Services B.V.
. Contact:
Tim Hulsen
. Read
here
our privacy notice.
Other websites of Indigonet Services B.V.:
Nieuws
Vacatures
News
Tweets
Nachrichten